About 6 Trademarks found that are owned by Skylinedx Bv

Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer

Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical use, namely oncology; preparations for detecting mutation in human genes for medical purposes

Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical use, namely medical diagnostic reagents and assays for testing of tissue for use in disease detection, namely oncology; preparations for detecting mutation in human genes for medical purposes

Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer

Software featuring algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the genetic properties of a patient sample; software for interpreting and analyzing raw genetic data for use by laboratory users, molecular biologists, pathologists, physicians and patients, for determining the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of a disease or clinical consequence thereof and prognosis, whether or not in combination with a specific treatment; computer software for operation of a validated, secure IT infrastructure for clinical purposes; downloadable databases featuring anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples; software operating and user manuals recorded on CDROMs featuring information on diagnostic testing

Software featuring algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the genetic properties of a patient sample; software for interpreting and analyzing raw genetic data for use by laboratory users, molecular biologists, pathologists, physicians and patients, for determining the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of a disease or clinical consequence thereof and prognosis, whether or not in combination with a specific treatment; computer software for operation of a validated, secure IT infrastructure for clinical purposes; downloadable databases featuring anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples; software operating and user manuals recorded on CDROMs featuring information on diagnostic testing

Software and computer software platform for centralized analysis of gene-expression data from genomic diagnostic tests

Genomic testing kits comprised of medical diagnostic reagents and assays for testing of bodily fluids and tissues in connection with genetic tests, clinical tests, prognostic tests or predictive tests for use in disease detection, namely, hematological disorders

Medical analysis services; analysis of medical and veterinary test scores and data for others; medical and veterinary information services provided via the internet

Software; software and algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the (complex) genetic properties of the patient sample; software for interpreting the obtained raw genetic information for inter alia laboratory users, molecular biologists, pathologists, physicians and patients, comprehensive and relevant information (such as the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of the disease or clinical consequence thereof as well as poor or good prognosis, whether or not in combination with a specific treatment); validated software for secure IT infrastructures for clinical purposes; databases containing anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples

Scientific research for the benefit of the development of molecular diagnostic tests; developing software for performing diagnostic tests for medical purposes, as well as developing software and algorithms and / or databases for translation (reading), analyzing and interpreting test results; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers, testing, and (corresponding) methods of treatment; leasing of computer software for reading test results; development and testing services for the certification of quality or standards of (molecular) diagnostic tests

Software; software and algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the (complex) genetic properties of the patient sample; software for interpreting the obtained raw genetic information for inter alia laboratory users, molecular biologists, pathologists, physicians and patients, comprehensive and relevant information (such as the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of the disease or clinical consequence thereof as well as poor or good prognosis, whether or not in combination with a specific treatment); validated software for secure IT infrastructures for clinical purposes; databases containing anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples